Hospice News March 18, 2025
The Pennant Group (Nasdaq: PNTG) is poised for more acquisitions as the year progresses, supported by a pipeline of newly trained leaders for acquired assets.
Pennant’s revenue growth has positioned the company well for more deals. During the fourth quarter the company accumulated $20.6 million in net cash generated from operating activities and $17.2 million in free cash flow.
When considering transactions, the company seeks out often struggling companies in its existing or expanded markets that earn between $3 million and $10 million in revenue and sell at a multiple of 5x to 8x for hospice companies.
“We have such a revolver, up to $250 million in the middle of last year, and we did an equity offering. As we...
Today's Sponsors
Today's Sponsor